Home › HIV › Missouri › Kansas City
HIV clinical trials in Kansas City, MO
5 studies for HIV are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
RecruitingObservational study
- KC Care Health Center, Kansas City
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
RecruitingPhase 3
- GSK Investigational Site, Kansas City
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
RecruitingPhase 2/3
- KC CARE Health Center ( Site 1506), Kansas City
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
RecruitingPhase 3
- KC CARE Health Center, Kansas City
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
RecruitingPhase 2
- GSK Investigational Site, Kansas City
About HIV
HIV (human immunodeficiency virus) attacks the body’s immune system. There is no cure but it can be treated with medicines. To know if you have HIV, get tested.
HIV trials in other cities
- Washington, DC22 studies
- New York City, NY19 studies
- Houston, TX17 studies
- Miami, FL17 studies
- Baltimore, MD16 studies
- San Francisco, CA15 studies
- Chicago, IL14 studies
- Atlanta, GA14 studies
- Philadelphia, PA11 studies
- Boston, MA11 studies
- San Diego, CA10 studies
- Los Angeles, CA9 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer31 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer19 studies
- Colorectal Cancer16 studies
- Metastatic Cancer15 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer14 studies
- Ovarian Cancer11 studies
- Obesity11 studies
- Type 2 Diabetes11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.